Copyright
©The Author(s) 2015.
World J Gastrointest Endosc. Dec 25, 2015; 7(19): 1341-1349
Published online Dec 25, 2015. doi: 10.4253/wjge.v7.i19.1341
Published online Dec 25, 2015. doi: 10.4253/wjge.v7.i19.1341
Figure 1 PRISMA flow chart.
Figure 2 Forest plot for incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis.
A: In non-steroidal anti-inflammatory drugs vs placebo groups; B: In rectal non-steroidal anti-inflammatory drugs vs placebo groups; C: In diclofenac vs placebo groups; D: In indomethacin vs placebo groups; E: In pre-endoscopic retrograde cholangiopancreatography non-steroidal anti-inflammatory drugs vs placebo groups; F: In post-endoscopic retrograde cholangiopancreatography non-steroidal anti-inflammatory drugs vs placebo groups. Odds ratios are shown with 95%CIs.
- Citation: Sajid MS, Khawaja AH, Sayegh M, Singh KK, Philipose Z. Systematic review and meta-analysis on the prophylactic role of non-steroidal anti-inflammatory drugs to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis. World J Gastrointest Endosc 2015; 7(19): 1341-1349
- URL: https://www.wjgnet.com/1948-5190/full/v7/i19/1341.htm
- DOI: https://dx.doi.org/10.4253/wjge.v7.i19.1341